Gen-Probe up on arbitration decision

GPRO gained $1.90 to $47.80 on Wednesday after announcing that it received a tentative award in its arbitration with Bayer (FSE:BAYG; BAY) related to the companies' 1998 deal for nucleic acid diagnost...